GSK-3beta inhibitor (Celon Pharma)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameGSK-3beta inhibitor (Celon Pharma)
Drug Alias Nameglycogen synthase kinase 3 beta inhibitor (Celon Pharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycogen synthase kinase-3 beta inhibitors
TargetsGlycogen synthase kinase-3 beta
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCelon Pharma SP
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelon Pharma SP
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A